omniture
Samsung Biologics Co. Ltd.

Latest News

Samsung Biologics breaks ground on Super Plant, the world's largest and most innovative bio-manufacturing facility

INCHEON, South Korea, Nov. 18, 2020 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) officially b...

2020-11-18 20:00 612

Samsung Biologics announces strategic manufacturing partnership with Lilly to accelerate delivery of COVID-19 antibody treatments

INDIANAPOLIS and INCHEON, South Korea, Nov. 17, 2020 /PRNewswire/ -- Samsung Biologics' partnership...

2020-11-17 20:00 483

Samsung Biologics' Virtual Exhibition Hall earns top industry award for digital creativity and innovation

INCHEON, South Korea, Oct. 4, 2020 /PRNewswire/ -- Samsung Biologics' Virtual Exhibition Hall was r...

2020-11-04 20:00 821

Samsung Biologics and Checkpoint Therapeutics Expand Manufacturing Partnership for Cosibelimab

INCHEON, South Korea and NEW YORK, Nov. 2, 2020 /PRNewswire/ -- Samsung Biologics Co., Ltd. ("Samsu...

2020-11-02 20:00 3258

Samsung Biologics Establishes Partnership with China Biotech GeneQuantum Healthcare to Collaborate on ADC Development

INCHEON, South Korea and SUZHOU, China, Nov. 1, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) ...

2020-11-02 08:27 543

Samsung Biologics expands global footprint with opening of new San Francisco CDO R&D Center

INCHEON, South Korea and SAN FRANCISCO, Oct. 28, 2020 /PRNewswire/ -- At a virtual ceremony today, ...

2020-10-29 08:38 5520

Samsung Biologics' strategic business operations continue to support strong third quarter earnings

INCHEON, South Korea, Oct. 21, 2020 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) maintained s...

2020-10-21 19:00 7161

Samsung Biologics inks development partnership with Dinona for potential COVID-19 treatment

INCHEON, South Korea, Oct. 20, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) has entered into ...

2020-10-20 19:00 8155

Samsung Biologics partners with BioEleven for cancer immunotherapy development and manufacturing

INCHEON, South Korea, Oct. 19, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) has entered into ...

2020-10-19 19:00 8768

Samsung Biologics signs strategic partnership with Kanaph Therapeutics to develop treatment for retinal diseases

INCHEON, South Korea, Sept. 23, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) and Kanaph Thera...

2020-09-24 08:00 806

Samsung Biologics and AstraZeneca forge strategic manufacturing partnership for global supply

INCHEON, South Korea, Sept. 21, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) and AstraZeneca ...

2020-09-22 07:00 11559

Samsung Biologics signs development agreement with Panolos for solid tumor treatment

INCHEON, South Korea, Sept. 16, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) has entered into...

2020-09-17 08:43 1108

Samsung Biologics launches S-CHOice cell line expression technology

INCHEON, South Korea, Aug. 4, 2020 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) today held an...

2020-08-05 09:09 1790

Samsung Biologics Posts Strong Second Quarter Earnings With 48.5% Increase In Sales

INCHEON, South Korea, July 21, 2020 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) announced to...

2020-07-21 20:20 15714

Samsung Biologics Expands Drug Product Manufacturing Facility in Incheon

SONGDO, South Korea, July 20, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) announced a plan t...

2020-07-21 10:13 15291

Samsung Biologics and ImmuneOncia sign multi-product development and manufacturing agreement

SONGDO, South Korea, July 15, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) and ImmuneOncia Th...

2020-07-15 13:46 875

Samsung Biologics signs additional development and manufacturing agreement with STCube

SONGDO, South Korea, July 11, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) has further expand...

2020-07-12 08:00 974

Samsung Biologics Unveils Virtual Exhibition Hall to Digitally Connect with Clients at BIO 2020

SONGDO, South Korea, June 8, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) announced the launc...

2020-06-08 19:00 495

GSK partners with Samsung Biologics to secure additional manufacturing capacity for innovative biopharmaceutical portfolio

LONDON and SONGDO, South Korea, May 21, 2020 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) an...

2020-05-22 07:11 5680

Samsung Biologics Expands Business Continuity Excellence with Additional ISO22301 Certification

SONGDO, South Korea, May 19, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) announced it has at...

2020-05-20 07:11 1036
12